Prostaglandin E1 nanoparticle - LTT Bio-Pharma

Drug Profile

Prostaglandin E1 nanoparticle - LTT Bio-Pharma

Alternative Names: LT-0101; Nano prostaglandin E1; Nano-PGE1

Latest Information Update: 16 Jul 2016

Price : $50 *
* Final gross price and currency may vary according to local VAT and billing address.
* Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase. A link to download a PDF version of the drug profile will be included in your email receipt. Adis is an information provider. We do not sell or distribute the pharmaceutical compounds written about in this database.

At a glance

  • Originator LTT Bio-Pharma
  • Class Prostaglandins
  • Mechanism of Action Prostaglandin E1 agonists
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

  • New Molecular Entity Yes

Highest Development Phases

  • Research Intermittent claudication; Spinal stenosis
  • No development reported Arterial occlusive disorders

Most Recent Events

  • 16 Jul 2016 No recent reports of development identified for research development in Arterial-occlusive-disorders in Japan (IV)
  • 14 Aug 2015 LTT Bio-Pharma has international patent protection for nanoparticles for drug delivery
  • 10 May 2010 Early research in Arterial occlusive disorders in Japan (IV)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top